Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 16.

Dressel, S; Gosselin, M C; Capstick, M H; Carrasco, E; Weyland, Mathias S; Scheidegger, Simon; Neufeld, Esra; Kuster, N; Bodis, S; Rohrer Bley, Carla (2017). Novel hyperthermia applicator system allows adaptive treatment planning: preliminary clinical results in tumour-bearing animals. Veterinary and Comparative Oncology:Epub ahead of print.

Datta, N R; Krishnan, S; Speiser, D E; Neufeld, E; Kuster, N; Bodis, S; Hofmann, H (2016). Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics? Cancer Treatment Reviews, 50:217-227.

Ghadjar, P; Hyoz, S; Bernhard, J; Zwahlen, D; Holscher, T; Gut, P; Guckenberger, M; Hildebrandt, G; Muller, A; Plasswilm, J; Papachristofilou, A; Stalder, L; Biaggi-Rudolf, C; Sumila, M; Kranzbuhler, H; Najafi, Y; Ost, P; Azinwi, N; Reuter, C; Bodis, S; Kaouthar, K; Wust, P; Thalmann, G; Aebersold, D (2015). Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10. Journal of Clinical Oncology, 33(35):4158-4166.

Datta, N R; Ordóñez, S Gómez; Gaipl, U S; Paulides, M M; Crezee, H; Gellermann, J; Marder, D; Puric, E; Bodis, S (2015). Local hyperthermia combined with radiotherapy and-/or chemotherapy: Recent advances and promises for the future. Cancer Treatment Reviews, 41(9):742-753.

Datta, N; Puric, E; Schneider, R; Weber, D C; Rogers, S; Bodis, S (2014). Could hyperthermia with proton therapy mimic carbon ion therapy? Exploring a thermo-radiobiological rationale. International Journal of Hyperthermia, 30(7):524-530.

Berberat, J; McNamara, J; Ramonda, L; Bodis, S; Rogers, S (2014). Diffusion tensor imaging for target volume definition in glioblastoma multiforme. Strahlentherapie und Onkologie, 190(10):939-943.

Datta, N; Samiei, M; Bodis, S (2014). Radiotherapy infrastructure and human resources in Europe - Present status and its implications for 2020. European Journal of Cancer, 50(15):2735-2743.

Datta, N; Samiei, M; Bodis, S (2014). Radiation therapy infrastructure and human resources in low- and middle-income countries: present status and projections for 2020. International Journal of Radiation Oncology, Biology, Physics, 89(3):448-457.

Datta, N; Puric, E; Schneider, R; Fuchs, B; Bodis, S; Weber, D (2014). HYPROSAR: Hyperthermia and proton radiotherapy in soft tissue sarcoma. Leading Opinions Hämatologie & Onkologie, (2):158-160.

Datta, N R; Puric, E; Bodis, S (2014). Hyperthermie in Kombination mit Strahlentherapie - Wirksamkeit bei Weichteilsarkomen und rezidivierenden Mammakarzinomen. info@onkologie, 4(3):34-36.

Ghadjar, P; Sun, H; Zimmermann, F; Bodis, S; Bernier, J; Studer, G; Aebersold, D M (2013). Physical examination during chemoradiation predicts outcome of locally advanced head and neck cancer. Secondary results of a randomized phase III trial (SAKK 10/94). Oral Oncology, 49(10):1006-1009.

Ghadjar, P; Simcock, M; Zimmermann, F; Betz, M; Bodis, S; Bernier, J; Studer, G; Aebersold, M (2012). Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94). Radiotherapy and Oncology, 104(2):213-218.

Lohse, I; Lang, S; Hrbacek, J; Scheidegger, S; Bodis, S; Macedo, N; Feng, J; Lütolf, U M; Zaugg, K (2011). Effect of high dose per pulse flattening filter-free beams on cancer cell survival. Radiotherapy and Oncology, 101(1):226-232.

Ribi, K; Bernhard, J; Schuller, J C; Weder, W; Bodis, S; Jörger, M; Betticher, D; Schmid, R A; Stupp, R; Ris, H B; Stahel, R A (2008). Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung Cancer, 61(3):398-404.

Lardinois, D; Jung, F J; Opitz, I; Rentsch, K; Latkoczy, C; Vuong, V; Varga, Z; Rousson, V; Günther, D; Bodis, S; Stahel, R; Weder, W (2006). Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma. Journal of Thoracic and Cardiovascular Surgery, 131(3):697-703.

Pruschy, M; Shi, Y Q; Crompton, N E; Steinbach, J P; Aguzzi, A; Glanzmann, C; Bodis, S (1997). The proto-oncogene c-fos mediates apoptosis in murine T-lymphocytes induced by ionizing radiation and dexamethasone. Biochemical and Biophysical Research Communications (BBRC), 241(2):519-524.

This list was generated on Tue Nov 21 00:28:01 2017 CET.